Skip to main content
. 2016 Apr 7;27(7):1304–1311. doi: 10.1093/annonc/mdw160

Figure 1.

Figure 1.

Progression-free survival curve by the type of PD-1 treatment. PD1: programmed cell death; aPD1: anti-PD-1 antibody; VEGFR-TKI: vascular endothelial growth factor receptor–tyrosine kinase inhibitor; mPFS: median progression-free survival; Mon: months; CI: confidence interval.